121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study

121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) Vol. 211; p. 114644
Main Authors: Boni, V., Antras, J. Fuentes, Garralda, E., Saavedra, O., Colombo, I., Stathis, A., Homicsko, K., Braña, I., Costanzo, S., Gruber, D., Cesano, A., Flückiger-Mangual, S.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114644